GE Healthcare and Takeda Pharmaceutical Co. have entered an R&D alliance to develop drugs as well as new diagnostic technologies targeting liver disease. GE will provide its diagnostic imaging technology to generate a liver stiffness map as part of Takeda’s research and development for liver diseases.   Liver disease has almost no visible symptoms, and its progress is characterized by a hardening of the tissues due to fibrosis. Over the past couple of decades, non-alcoholic fatty liver disea...